Search results for "relapse"

South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name: anbalcabtagene autoleucel) was deemed...
Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone

Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone

For patients with aggressive blood cancers that recur or fail to respond to standard chemotherapy, chimeric antigen receptor T-cell (CAR-T)...
Blurry Vision and Sudden Limb Weakness Could Signal Multiple Sclerosis, Not Just Stroke

Blurry Vision and Sudden Limb Weakness Could Signal Multiple Sclerosis, Not Just Stroke

When vision suddenly turns cloudy in one eye and an arm or leg feels unexpectedly weak, many patients immediately fear...
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
More Than an AC Chill: Why That Scratchy Summer Throat Might Be Tonsillitis

More Than an AC Chill: Why That Scratchy Summer Throat Might Be Tonsillitis

Unprecedented summer heat has arrived. Even though it is only early July, daytime highs in several regions have already...
Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Treatment for inflammatory bowel disease is rapidly moving beyond simple symptom management toward the structural...
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage.
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
The Art of Healthy Aging: What Youn Yuh-jung and Paul McCartney Teach Us About Staying Sharp

The Art of Healthy Aging: What Youn Yuh-jung and Paul McCartney Teach Us About Staying Sharp

Academy Award-winning actress Youn Yuh-jung, 79, is frequently celebrated as a global symbol of natural aging and...
When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults

When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults

When recurring abdominal pain and diarrhea strike, most people first assume they are dealing with a standard bout of...